Molecular mechanism of histamine clearance by primary human astrocytes

GLIA

Volumn 61, Issue 6, 2013, Pages 905-916

  Yoshikawa, Takeo ^a   Naganuma, Fumito ^a   Iida, Tomomitsu ^a   Nakamura, Tadaho ^a   Harada, Ryuichi ^a   Mohsen, Attayeb S ^a   Kasajima, Atsuko ^a   Sasano, Hironobu ^a   Yanai, Kazuhiko ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Astrocytes; Histamine; Histamine N methyltransferase; Low affinity transporters

Indexed keywords

CARRIER PROTEIN; HISTAMINE METHYLTRANSFERASE; OCTAMER TRANSCRIPTION FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; PLASMA MEMBRANE MONOAMINE TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; FETUS; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTRACELLULAR TRANSPORT; MOLECULAR BIOLOGY; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ASTROCYTES; BIOLOGICAL TRANSPORT; BRAIN; CELL LINE, TUMOR; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; HISTAMINE; HISTAMINE N-METHYLTRANSFERASE; HUMANS; NEURONS; ORGANIC CATION TRANSPORT PROTEINS;

EID: 84876474017     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22484     Document Type: Article

References (46)

1. Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry 2011;17:926-939.
2. Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC. Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci USA 2008;105:18976-18981.
3. Balasooriya I, Wimalasena K. Are SH-SY5Y and MN9D cell lines truly dopaminergic? Proceedings of the 3rd Annual GRASP Symposium. Wichita, KS: Wichita State University, 2007. pp 25-26.
4. Barnes WG, Grinde E, Crawford DR, Herrick-Davis K, Hough LB. Characterization of a new mRNA species from the human histamine N-methyltransferase gene. Genomics 2004;83:168-171.
5. Barnes WG, Hough LB. Membrane-bound histamine N-methyltransferase in mouse brain: Possible role in the synaptic inactivation of neuronal histamine. J Neurochem 2002;82:1262-1271.
6. Brown DD, Tomchick R, Axelrod J. The distribution and properties of a histamine-methylating enzyme. J Biol Chem 1959;234:2948-2950.
7. Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, Arndt P, Ulzheimer JC, Sonders MS, Baumann C, Waldegger S, Lang F, Koepsell H. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 1998;54:342-352.
8. Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 2009;106:8043-8048.
9. Dahlin A, Xia L, Kong W, Hevner R, Wang J. Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 2007;146:1193-1211.
10. Duan H, Wang J. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 2010;335:743-753.
11. Engel K, Zhou M, Wang J. Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 2004;279:50042-50049.
12. Ercan-Sencicek AG, Stillman AA, Ghosh AK, Bilguvar K, O'Roak BJ, Mason CE, Abbott T, Gupta A, King RA, Pauls DL, Tischfield JA, Heiman GA, Singer HS, Gilbert DL, Hoekstra PJ, Morgan TM, Loring E, Yasuno K, Fernandez T, Sanders S, Louvi A, Cho JH, Mane S, Colangelo CM, Biederer T, Lifton RP, Gunel M, State MW. L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010;362:1901-1908.
13. Esbenshade TA, Browman KE, Bitner RS, Strakhova M, Cowart MD, Brioni JD. The histamine H3 receptor: An attractive target for the treatment of cognitive disorders. Br J Pharmacol 2008;154:1166-1181.
14. Fernandez TV, Sanders SJ, Yurkiewicz IR, Ercan-Sencicek AG, Kim YS, Fishman DO, Raubeson MJ, Song Y, Yasuno K, Ho WS, Bilguvar K, Glessner J, Chu SH, Leckman JF, King RA, Gilbert DL, Heiman GA, Tischfield JA, Hoekstra PJ, Devlin B, Hakonarson H, Mane SM, Gunel M, State MW. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry 2012;71:392-402.
15. Grundemann D, Koster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, Obermuller N, Schomig E. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 1998a;273:30915-30920.
16. Grundemann D, Schechinger B, Rappold GA, Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1998b;1:349-351.
17. Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003;4:121-130.
18. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008;88:1183-1241.
19. Hirokawa T, Boon-Chieng S, Mitaku S. SOSUI: Classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998;14:378-379.
20. Horton JR, Sawada K, Nishibori M, Zhang X, Cheng X. Two polymorphic forms of human histamine methyltransferase: Structural, thermal, and kinetic comparisons. Structure 2001;9:837-849.
21. Huszti Z. Carrier-mediated high affinity uptake system for histamine in astroglial and cerebral endothelial cells. J Neurosci Res 1998;51:551-558.
22. Huszti Z. Histamine uptake into non-neuronal brain cells. Inflamm Res 2003;52(Suppl 1):S03-S06.
23. Huszti Z, Prast H, Tran MH, Fischer H, Philippu A. Glial cells participate in histamine inactivation in vivo. Naunyn Schmiedebergs Arch Pharmacol 1998;357:49-53.
24. Inazu M, Takeda H, Matsumiya T. Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. J Neurochem 2005;94:1427-1437.
25. Iversen LL. The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: A novel catechol amine uptake process. Br J Pharmacol Chemother 1965;25:18-33.
26. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007;24:1227-1251.
27. Kuhar MJ, Taylor KM, Snyder SH. The subcellular localization of histamine and histamine methyltransferase in rat brain. J Neurochem 1971;18:1515-1527.
28. Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: Identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 2005;314:1310-1321.
29. Nishibori M, Tahara A, Sawada K, Sakiyama J, Nakaya N, Saeki K. Neuronal and vascular localization of histamine N-methyltransferase in the bovine central nervous system. Eur J Neurosci 2000;12:415-424.
30. Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K, Mignot E. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 2009;32:175-180.
31. Ogasawara K, Terada T, Asaka J, Katsura T, Inui K. Human organic anion transporter 3 gene is regulated constitutively and inducibly via a cAMP-response element. J Pharmacol Exp Ther 2006;319:317-322.
32. Okuda M, Urakami Y, Saito H, Inui K. Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes. Biochim Biophys Acta 1999;1417:224-231.
33. Pierleoni A, Martelli PL, Casadio R. PredGPI: A GPI-anchor predictor. BMC Bioinformatics 2008;9:392.
34. Rafalowska U, Waskiewicz J, Albrecht J. Is neurotransmitter histamine predominantly inactivated in astrocytes? Neurosci Lett 1987;80:106-110.
35. Riederer P, Konradi C, Schay V, Kienzl E, Birkmayer G, Danielczyk W, Sofic E, Youdim MB. Localization of MAO-A and MAO-B in human brain: A step in understanding the therapeutic action of L-deprenyl. Adv Neurol 1987;45:111-118.
36. Schneider E, Machavoine F, Pleau JM, Bertron AF, Thurmond RL, Ohtsu H, Watanabe T, Schinkel AH, Dy M. Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels. J Exp Med 2005;202:387-393.
37. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991;71:1-51.
38. Sofroniew MV, Vinters HV. Astrocytes: Biology and pathology. Acta Neuropathol 2010;119:7-35.
39. Takeda H, Inazu M, Matsumiya T. Astroglial dopamine transport is mediated by norepinephrine transporter. Naunyn Schmiedebergs Arch Pharmacol 2002;366:620-623.
40. Tashiro M, Yanai K. [Molecular imaging of histamine receptors in the human brain]. Brain Nerve 2007;59:221-231.
41. Walz W, Lang MK. Immunocytochemical evidence for a distinct GFAP-negative subpopulation of astrocytes in the adult rat hippocampus. Neurosci Lett 1998;257:127-130.
42. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 1998;273:32776-32786.
43. Wultsch T, Grimberg G, Schmitt A, Painsipp E, Wetzstein H, Breitenkamp AF, Grundemann D, Schomig E, Lesch KP, Gerlach M, Reif A. Decreased anxiety in mice lacking the organic cation transporter 3. J Neural Transm 2009;116:689-697.
44. Yanai K, Son LZ, Endou M, Sakurai E, Nakagawasai O, Tadano T, Kisara K, Inoue I, Watanabe T, Watanabe T. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience 1998;87:479-487.
45. Yoshizawa M, Tashiro M, Fukudo S, Yanai K, Utsumi A, Kano M, Karahasi M, Endo Y, Morisita J, Sato Y, Adachi M, Itoh M, Hongo M. Increased brain histamine H1 receptor binding in patients with anorexia nervosa. Biol Psychiatry 2009;65:329-335.
46. Zwart R, Verhaagh S, Buitelaar M, Popp-Snijders C, Barlow DP. Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol 2001;21:4188-4196.